IntronA

Medicinal product

(Invented) name

IntronA

Active substance (s)

Interferonas alfa-2b

Strength

10 mln. TV/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L03AB05, Interferon alfa-2b

Marketing authorisation holder

Merck Sharp & Dohme B.V., Nyderlandai

Date of authorisation

2000-03-09

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Solution for injection or infusion	1 ml
Interferonas alfa-2b	10 mln. TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
25966	28558	1028558	flakonas	1 ml N1		Receptinis	EU/1/99/127/019	Netiekiama	-	-	No	-	-
25967	28559	1028559	flakonas	injekcinis švirkštas, injekcinė adata ir tamponas N1		Receptinis	EU/1/99/127/020	Netiekiama	-	-	No	-	-
25968	28560	1028560	flakonas	injekcinis švirkštas, injekcinė adata ir tamponas N6		Receptinis	EU/1/99/127/021	Netiekiama	-	-	No	-	-
25969	28561	1028561	flakonas	injekcinis švirkštas, injekcinė adata ir tamponas N12		Receptinis	EU/1/99/127/022	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-12-01	Išregistruotas
2000-03-09	Registruotas